How to Make Clinical Trials for Elderly with Disabilities More Inclusive
The global demographic is undergoing a significant shift, with an increasing number of elderly patients. This aging population brings...
Moe Alsumidaie
How to Bolster Clinical Operations in the Post-COVID-19 Pandemic World
Clinical Operations, the backbone of the clinical trials sector, has been impacted by the COVID-19 pandemic. Post-pandemic, many clinical...
Reducing Patient Burden in Clinical Trials: How to Make Trials More Feasible for Patients
In the realm of medical advancements, there’s a growing concern that’s capturing the attention of the clinical research community:...
Diversity in Clinical Trials: What You Need to Know
In the age of precision medicine, clinical trials are foundational. Their outcomes shape the drugs we use, the treatments...
DCTs, BYOD and VR: A New Era for Ophthalmology Trials
In the rapidly evolving landscape of clinical research, Decentralized Clinical Trials (DCTs) are emerging as a transformative approach, redefining...
Starting a Study Site: Navigating Research Opportunities and Challenges
In the expansive world of medical and clinical trials, there’s an ever-growing emphasis on starting a study site and...
Clinical Trials for Nanotechnology: Pioneering the Future of Cancer
The transformative potential of nanotechnology in healthcare is undeniable. Specifically, its revolutionary impact on cancer therapy is becoming clearer...
Future of The Informed Consent Process in Clinical Trials
Central to the evolution of the realm of clinical research is the Informed Consent Process, the bedrock of clinical...
The Bold Challenge Of Clinical Trials Professionals
In the rapidly evolving landscape of medical advancements, clinical research, and clinical trials have always been the silent sentinel,...
Elrexfio: New Bispecific Antibody Therapy for Multiple Myeloma
The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Pfizer’s Elrexfio, a groundbreaking bispecific antibody therapy...